Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases

This study is currently recruiting participants.

Study NCT00079001 Information provided by National Cancer Institute (NCI)

First Received: March 8, 2004 Last Updated: November 21, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	January 2008 (Final data collection date for primary outcome measure)